Your browser doesn't support javascript.
loading
Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?
Catalán, Maria José; Antonini, Angelo; Calopa, Matilde; Bajenaru, Ovidiu; de Fábregues, Oriol; Mínguez-Castellanos, Adolfo; Odin, Per; García-Moreno, José Manuel; Pedersen, Stephen W; Pirtosek, Zvezdan; Kulisevsky, Jaime.
Afiliación
  • Catalán MJ; Parkinson and Movement Disorders Unit, Hospital Clínico San Carlos, Madrid, Spain.
  • Antonini A; Parkinson and Movement Disorders Unit, Department of Neurosciences, IRCCS Hospital San Camillo, Venice, Italy.
  • Calopa M; Hospital Universitari de Bellvitge, Barcelona, Spain.
  • Bajenaru O; University of Medicine and Pharmacy "Carol Davila" Bucharest - University Emergency Hospital, Department of Neurology, Bucharest, Romania.
  • de Fábregues O; Vall d'Hebron University Hospital, Neurology Service, Movement Disorders Unit, Autonomous University of Barcelona, Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Mínguez-Castellanos A; Complejo Hospitalario Universitario de Granada, Instituto de Investigación Biosanitaria "ibs. Granada,", Granada, Spain.
  • Odin P; Skåne University Hospital, Lund University, Lund, Sweden.
  • García-Moreno JM; Klinikum-Bremerhaven, Bremerhaven, Germany.
  • Pedersen SW; Hospital Universitario Virgen Macarena, Seville, Spain.
  • Pirtosek Z; University of Copenhagen, Rigshospitalet Glostrup, Glostrup, Denmark.
  • Kulisevsky J; University Medical Centre, Ljubljana, Slovenia.
eNeurologicalSci ; 8: 44-53, 2017 Sep.
Article en En | MEDLINE | ID: mdl-29260038